Skip to main content
OpenTrials

Clinical trial condition

Urinary Bladder Neoplasms

Explore clinical trials studying Urinary Bladder Neoplasms. Study availability and eligibility vary by location and protocol.

67 public trials 15 recruiting studies
Refine in advanced search Browse all conditions

Urinary Bladder Neoplasms trial results

Completed

MK-7684A With or Without Other Anticancer Therapies in Participants With Selected Solid Tumors (MK-7684A-005) (KEYVIBE-005)

NCT05007106

Conditions
Adenocarcinoma, Adnexal Diseases, Biliary Tract Diseases, +52 more
Locations
  • Alaska Womens Cancer Care ( Site 1016) Anchorage, Alaska, United States
  • City of Hope Comprehensive Cancer Center ( Site 1001) Duarte, California, United States
  • University of California, Irvine (UCI) Health - UC Irvine Me-Chao Family Comprehensive Cancer Cente Orange, California, United States
  • Karmanos Cancer Institute ( Site 1007) Detroit, Michigan, United States
View all 73 locations
View Trial Details
Completed

Proliposomal Intravesical Paclitaxel for Treatment of Low-Grade, Stage Ta, Non Muscle Invasive Bladder Cancer

NCT03081858

Conditions
Bladder Cancer, Bladder Cancer Cell Transitional, Carcinoma, +17 more
Locations
  • Urological Associates of Southern Arizona, PC Tucson, Arizona, United States
  • Trovare Clinical Research Bakersfield, California, United States
  • Tower Urology Los Angeles, California, United States
  • Chesapeake Urology Associates Hanover, Maryland, United States
View Trial Details
Completed

A Study of TAR-200 in Participants With Muscle-Invasive Urothelial Carcinoma of the Bladder Who Are Ineligible for or Refuse Cisplatin-based Chemotherapy and Who Are Unfit for Radical Cystectomy

NCT03404791

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, +8 more
Locations
  • Mayo Clinic Arizona Phoenix, Arizona, United States
  • North Georgia Urology Center Dalton, Georgia, United States
  • Chesapeake Urology Research Associates Hanover, Maryland, United States
  • Michigan Institute of Urology Troy, Michigan, United States
View Trial Details
Completed

Phase I/Ib Study of Pembrolizumab With Vorinostat for Patients With Advanced Renal or Urothelial Cell Carcinoma

NCT02619253

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +16 more
Locations
  • USC/Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Indiana University Hospital Indianapolis, Indiana, United States
  • Indiana University Melvin and Bren Simon Cancer Center Indianapolis, Indiana, United States
  • Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States
View Trial Details
Completed

A Study of Enfortumab Vedotin for Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer

NCT03219333

Conditions
Carcinoma, Carcinoma, Transitional Cell, Female Urogenital Diseases, +18 more
Locations
  • Alaska Urological Institute Anchorage, Alaska, United States
  • Arizona Oncology Associates, PC - HAL Goodyear, Arizona, United States
  • Mayo Clinic Arizona Phoenix, Arizona, United States
  • Arizona Oncology Associates, PC - HOPE Tucson, Arizona, United States
View all 81 locations
View Trial Details
Completed

The Bladder Instillation Comparison Study

NCT02695771

Conditions
Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +12 more
Locations
  • Spectrum Health Medical Group-Division of Urology-LHCP Grand Rapids, Michigan, United States
  • Spectrum Health Medical Group-Division of Urology Grand Rapids, Michigan, United States
  • Urologic Consultants P.C. Grand Rapids, Michigan, United States
View Trial Details

Related conditions